SCHEMBL17429671

SCHEMBL17429671

COC(=O)c1ccc(OCCc2cc(C)cc(C)c2)c(Br)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ TDP1 Q9NUW8 3/20 0.44
▸ NOTUM Q6P988 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ F2 P00734 1/20 0.42
▸ PLAU P00749 1/20 0.42
▸ ST14 Q9Y5Y6 1/20 0.42
▸ CCR6 P51684 1/20 0.41
▸ HKDC1 Q2TB90 1/20 0.41
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ THRA P10827 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ TTR P02766 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17386038 0.92 ALDH1A1 (0.41) KDM4EUSP2TDP1NOTUMALDH1A1
SCHEMBL6294921 0.81 THRA (0.51) KDM4ENOTUMALDH1A1LMNAMEN1
SCHEMBL15068193 0.81 NOTUM (0.50) KDM4EUSP2TDP1NOTUMALDH1A1
SCHEMBL31092597 0.80 NOTUM (0.47) KDM4EUSP2TDP1NOTUMALDH1A1
SCHEMBL10269561 0.80 THRA (0.56) KDM4ENOTUMALDH1A1MEN1KMT2A
SCHEMBL21854518 0.80 NOTUM (0.49) KDM4EUSP2TDP1NOTUMALDH1A1
SCHEMBL10876459 0.80 F2 (0.50) KDM4EUSP2TDP1NOTUMALDH1A1
SCHEMBL1995897 0.79 MEN1 (0.49) TDP1ALDH1A1LMNAMEN1KMT2A
SCHEMBL17429649 0.78 P4HB (0.46) KDM4EUSP2TDP1NOTUMALDH1A1
SCHEMBL6601501 0.78 MAPT (0.59) KDM4ENOTUMALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 KDM4E 3682/4885USP2 4733/4885TDP1 4431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback